Search

everythinglearnresearchcommunity

for

Search:↓

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Young girls whose mothers have PCOS may have higher activity of a specific enzyme that could lead to developing PCOS later.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Four circRNAs were found to be significantly different in cashmere goat skin, affecting cashmere fineness.

The hair follicle pathway significantly affects how easily water-loving chemicals pass through the skin.

Using steroids can increase the risk of heart problems.

Blocking CRF-R1 can reduce alcohol intake in stressed mice.

People with early onset baldness have higher bad cholesterol and lower good cholesterol, increasing their heart disease risk.

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

Early diagnosis and treatment of TPP can prevent complications.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

The document concludes that there is no agreed-upon best method for measuring drug delivery within hair follicles and more research is needed to validate current techniques.

Cepharanthine may help treat gastric cancer by causing cancer cell death and affecting energy use.

FPHL common in Taiwanese women; risk factors include BMI, high glucose, early puberty, fewer childbirths, oral contraceptives, and UV exposure.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

Eating disorders can cause skin problems that need treating the underlying condition for better health.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

People with psoriasis are more likely to have Metabolic Syndrome than those without psoriasis.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

Early adrenal gland maturation in young children can be normal, but other serious conditions should be ruled out first.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.